Ilo Leppik, MD
Professor, College of Pharmacy
University of Minnesota
James W. Cooper, RPh, PhD, BCPS, CGP, FASCP
Emeritus Professor and Consultant
Department of Clinical and Administrative Pharmacy
College of Pharmacy
University of Georgia
0.5 Contact Hours (0.05 CEU)
Podcast (MP3 & PDF)
Epilepsy is an increasingly prevalent condition among elderly patients. Up to 50% of first-time seizures have been found to occur in people over the age of 65 years, and nearly 25% of those with epilepsy are elderly. However, despite the pervasiveness of this condition among senior populations, surveys of clinicians and senior-care pharmacists suggest a deficiency in knowledge regarding proper utilization of antiepileptic drug (AED) therapy. Moreover, recent interviews with clinical experts revealed a number of barriers to optimal epilepsy care in the elderly, including diagnosis and treatment delays, underuse of newer AEDs, and presence of comorbidities, drug–drug interactions, and acute and long-term side effects.
It is imperative that consultant and senior care pharmacists be prepared to address these barriers in their elderly patients. Taking steps to tailor epilepsy therapy to this specific patient population will likely improve patient care in elderly individuals with epilepsy.
. Target Audience
Consultant and senior care pharmacists
Upon completion of this knowledge-based educational activity, the participant should be able to:
Discuss the latest research findings on the epidemiology of epilepsy in the elderly.
Identify the latest research findings on the underlying etiology of epilepsy in the elderly.
Describe how the characteristics of older and newer antiepileptic drugs should guide AED selection.
In accordance with the standards set forth by the Accreditation Council for Pharmacy Education, it is the policy of the American Society of Consultant Pharmacists to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any relevant financial relationships or other relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation.
The intent of this disclosure is not to prevent a presenter with relevant financial relationships or other relationships from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker¹s interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Drs. Leppik and Cooper disclose that they have no real or perceived conflicts of interest that relate to this presentation.
This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
PHARMACY CONTINUING EDUCATION: The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity (ACPE # 203‐999‐10‐005‐H01‐P) was developed by ASCP and is approved for 0.5 Contact Hour (0.05 CEU).
Participants must view the activity in its entirety, successfully complete the post‐test, and submit an evaluation to receive continuing pharmacy education credit. Credit will be awarded for a score of 70% or better, and a statement may be printed immediately after passing the post‐test. Commercial Support Statements
Supported through an educational grant from UCB, Inc.
This activity consists of a Podcast/MP3 audio file and a link to an online post-test and program evaluation that can be submitted for credit and/or used to assist learning. A PDF of the CPE information, post-test, and evaluation is also available. You may play the audio online or download the file to an MP3 audio player, such as an iPod. You will need Adobe Acrobat Reader to view and print the PDF post-test and evaluation.
Click on the "Start program" icon. This will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or check/revise existing registration information.
Update your existing registration information, if necessary. When ready, click on the "Continue to Program" icon at the top or bottom of the screen. This will take you to the podcast description page for CMEcorner2go.
Save the PDF file to your computer or open the file using the Adobe Acrobat Reader. Print a copy of the PDF, which includes the CPE information and a link to the online post-test and activity evaluation.
Download or play the audio file by clicking on the appropriate button. Instructions for utilizing this activity on a portable MP3 player such as an iPod can be found on this page.
Listen to the presentation before completing the post-test and evaluation. It should take approximately 30 minutes to listen to the audio and complete the post-test and evaluation.
To receive CPE credit, follow the link to the post-test. Successful completion of the online post-test and evaluation will enable you to immediately print a statement of credit.
None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational program are those of the presenters and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the American Society of Consultant Pharmacists, or UCB S.A. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other healthcare professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.